By ANDREW POLLACK
Identifying which patients are likely to benefit from expensive treatments such as Opdivo, Yervoy and Keytruda could save money and prevent side effects.
Published: June 1, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1KvXg39
from WordPress http://ift.tt/1d73vzo
via Hadi Aboukhater
No comments:
Post a Comment